NCT Number: NCT00144040
Improving Antibiotic Use in Acute Care Treatment
Purpose The emergence and rapid rise in antibiotic resistance among common bacteria are adversely affecting the clinical course and health care costs of community-acquired infections. Because antibiotic resistance rates are strongly correlated with antibiotic use patterns, multiple organizations have declared reductions in unnecessary antibiotic use to be critical components of efforts to combat antibiotic resistance. Among humans, the vast majority of unnecessary antibiotic prescriptions are used to treat acute respiratory tract infections (ARIs) that have a viral etiology. Although the rate of antibiotic prescribing for ARIs by office-based physicians in the US has decreased about 16% from its peak in 1997, the rate of antibiotic prescribing in acute care settings (eg, emergency departments and urgent care centers), which account for 1 in 5 ambulatory antibiotic prescriptions in the US, has shown only a modest decline (6%) during this period. Translation of lessons from intervention studies in office-based practices is needed to improve antibiotic use in acute care settings.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
VA San Diego Healthcare System, San Diego, CA, San Diego, California, United States
About this study
Objectives:
Specific Aim 1: To evaluate the impact of a multidimensional (patient, system, clinician) intervention on appropriate antibiotic use for adults with acute respiratory tract infections-- identifying factors that influence successful translation across VA hospital and non-VA hospital acute care. Specific Aim 2: To evaluate the impact of a rapid diagnostic test for c-reactive protein on antibiotic use for adults with acute cough illness when added to a multidimensional intervention.
Methods:
We propose to conduct a randomized controlled trial of a quality improvement program consisting of physician education (educational seminar, practice guidelines, performance feedback, and decision support tools) and patient education (waiting room print and audiovisual materials) in 8 VA hospital and 8 non-VA hospital emergency departments. Non VA study sites will be identified from an existing research network of hospital emergency departments--EDNet. VA hospital sites will be selected among academically affiliated hub facilities. Phase one will involve a hospital-level randomized trial of a multidimensional intervention to translate existing evidence based guidelines for antibiotic use in ARIs vs. usual care. Simultaneously, we will validate a new CRP-based diagnostic algorithm and incorporate it into the evidence based guidelines for antibiotic use in ARIs. Phase two will involve a second hospital-level randomized trial of the new antibiotic use guidelines that incorporate the CRP-based diagnostic algorithm vs. the original guidelines. Specific endpoints include the overall success of the intervention in each phase in terms of reducing antibiotic prescribing for ARIs, improving patient outcomes and reducing resource utilization. In addition we will examin the impact of VA and non-VA organizational factors on the successful translation of various components of the intervention in both phases. Data will be collected using existing administrative data as well as on-site enrollment of subjects in prospective follow-up studies.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Emergency room patient
- Selected VA or Non-VA patients
- Age 18 years or older
- Patient must have acute respiratory illness
- Patient must not have been seen in Emergency Department within 4 weeks
Exclusion criteria
- Patients less than 18 years of age
- Patient in Emergency Department for non-acute respiratory infection
Treatment and study plan
Rapid C-reactive protein testing to guide antibiotic treatment
ProcedurePrimary outcomes
-
Proportion of all acute respiratory infection visits treated with antibiotics
Secondary outcomes
-
Delayed antibiotic treatment of acute respiratory infections; Patient satisfaction
Sponsors and collaborators
Lead sponsor
US Department of Veterans Affairs
Fed
Collaborators
- Agency for Healthcare Research and Quality (AHRQ)
Registry information
Official study title
Improving Antibiotic Use in Acute Care Setting
Acronym: IMPAACT
Important dates
- Study start
- 2004
- Study completion
- 2007
- First posted
- Sep 2, 2005
- Registry last updated
- Apr 7, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Vitamin D for Sickle-cell Respiratory Complications
NCT01443728
Acute Chest Syndrome, Anemia
New York, United States
View Trial DetailsA Clinical Trial of Nebulized Surfactant for the Treatment of Moderate to Severe COVID-19
NCT04362059
Infections, Respiratory Infections
Southampton, Hampshire, United Kingdom
View Trial DetailsInfluenza in People With Normal and Weakened Immune Systems
NCT00533182
Infections, Influenza, Human
Bethesda, Maryland, United States
View Trial DetailsHigh/Low Dose Vit A in Diarrhea/ALRI in Severe PEM
NCT00388921
Body Weight, Common Cold
Dhaka, Bangladesh
View Trial Details